Advances in Lipidomics: Biomedicine, Nutrients and Methodology
This book contains 12 articles covering biomedicine, nutrition, and the methodology of lipidomics . These works were first published by MDPI in a Special Issue of Metabolites. Phospholipids, sphingolipids, glyosylinositolphosphoceramides, cholesteryl esters, acyl-carnitines, and oxylipins are within...
Saved in:
| HerausgeberIn: | |
|---|---|
| Sonstige: | |
| Year of Publication: | 2021 |
| Language: | English |
| Physical Description: | 1 electronic resource (248 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04415nam-a2201273z--4500 | ||
|---|---|---|---|
| 001 | 993545933604498 | ||
| 005 | 20231214133140.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202201s2021 xx |||||o ||| 0|eng d | ||
| 035 | |a (CKB)5400000000042858 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/76590 | ||
| 035 | |a (EXLCZ)995400000000042858 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Montero, Olimpio |4 edt | |
| 245 | 1 | 0 | |a Advances in Lipidomics: Biomedicine, Nutrients and Methodology |
| 246 | |a Advances in Lipidomics | ||
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (248 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | |a Open access |f Unrestricted online access |2 star | ||
| 520 | |a This book contains 12 articles covering biomedicine, nutrition, and the methodology of lipidomics . These works were first published by MDPI in a Special Issue of Metabolites. Phospholipids, sphingolipids, glyosylinositolphosphoceramides, cholesteryl esters, acyl-carnitines, and oxylipins are within the lipid classes accounted for studies regarding liver disease, Wilson disease, kidney disease, cardiovascular disease, adipogenesis, and the role lipids play in cancer and virus infection. High-throughput lipid extraction and guidelines for lipid annotation are addressed in several papers. This book is expected to provide a comprehensive view of the diverse areas where lipidomics looms largest. | ||
| 546 | |a English | ||
| 650 | 7 | |a Research & information: general |2 bicssc | |
| 653 | |a chronic kidney disease | ||
| 653 | |a leptin | ||
| 653 | |a fatty acids | ||
| 653 | |a adipose tissue | ||
| 653 | |a adipocytes | ||
| 653 | |a adipogenesis | ||
| 653 | |a differential mobility spectrometry (DMS) | ||
| 653 | |a lipidomics | ||
| 653 | |a lipidyzer | ||
| 653 | |a mass spectrometry | ||
| 653 | |a metabolomics | ||
| 653 | |a phenotyping | ||
| 653 | |a Simpson-Golabi-Behmel syndrome (SGBS) | ||
| 653 | |a COX | ||
| 653 | |a CYP450 | ||
| 653 | |a LOX | ||
| 653 | |a oxylipins | ||
| 653 | |a PUFAs | ||
| 653 | |a UPLC-MS/MS | ||
| 653 | |a copper | ||
| 653 | |a Wilson’s disease | ||
| 653 | |a lipidomic | ||
| 653 | |a liquid chromatography | ||
| 653 | |a tandem mass spectrometry | ||
| 653 | |a molecular network | ||
| 653 | |a dry eye disease | ||
| 653 | |a hyperosmolarity | ||
| 653 | |a cardiovascular disease | ||
| 653 | |a heart failure | ||
| 653 | |a myocardial infarction | ||
| 653 | |a obesity | ||
| 653 | |a diabetic cardiomyopathy | ||
| 653 | |a dilated cardiomyopathy | ||
| 653 | |a lipids | ||
| 653 | |a odd chain lipids | ||
| 653 | |a lipid profiling | ||
| 653 | |a Folch | ||
| 653 | |a protein precipitation | ||
| 653 | |a sample preparation | ||
| 653 | |a relative lipid composition (Mol%) | ||
| 653 | |a atopic dermatitis | ||
| 653 | |a SHARPIN-deficient mice | ||
| 653 | |a flow-injection mass-spectrometry | ||
| 653 | |a predictive elastic net | ||
| 653 | |a immunotherapy | ||
| 653 | |a cancer | ||
| 653 | |a biomarkers | ||
| 653 | |a metabolism | ||
| 653 | |a cancer cell membranes | ||
| 653 | |a fatty acid biosynthesis | ||
| 653 | |a essential fatty acids | ||
| 653 | |a desaturase enzymes | ||
| 653 | |a fatty acid signaling | ||
| 653 | |a fatty acid biomarker | ||
| 653 | |a sapienic acid | ||
| 653 | |a sebaleic acid | ||
| 653 | |a molecular nutrition | ||
| 653 | |a inflammation | ||
| 653 | |a drug-induced liver injury | ||
| 653 | |a biomarker | ||
| 653 | |a plasma lipid profiles | ||
| 653 | |a ssRNA+ virus | ||
| 653 | |a membrane fusion | ||
| 653 | |a lipid metabolism | ||
| 653 | |a cholesterol | ||
| 653 | |a sphingolipids | ||
| 653 | |a phosphatidylinositol | ||
| 653 | |a SARS-CoV | ||
| 653 | |a glycolipidomics | ||
| 653 | |a GIPC | ||
| 653 | |a glycosyl inositol phospho ceramides | ||
| 653 | |a Lipid Data Analyzer | ||
| 653 | |a ultra-high pressure liquid chromatography | ||
| 653 | |a high-resolution mass spectrometry | ||
| 653 | |a LC-MS | ||
| 653 | |a automated annotation | ||
| 776 | |z 3-0365-1186-5 | ||
| 776 | |z 3-0365-1187-3 | ||
| 700 | 1 | |a Balgoma, David |4 edt | |
| 700 | 1 | |a Gil-de-Gómez, Luis |4 edt | |
| 700 | 1 | |a Montero, Olimpio |4 oth | |
| 700 | 1 | |a Balgoma, David |4 oth | |
| 700 | 1 | |a Gil-de-Gómez, Luis |4 oth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:44:12 Europe/Vienna |f system |c marc21 |a 2022-04-04 09:22:53 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338092670004498&Force_direct=true |Z 5338092670004498 |b Available |8 5338092670004498 | ||